SLC6A3 and Parkinson disease: Functional imaging techniquessuch as dopamine transporter (DAT) imaging with single-photon emissioncomputed tomography (SPECT) or positron emission tomography (PET)can assess dopamine transporter activity in the brain, which is typicallyreduced in PD.